Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Newest-generation Evolut TAVI system builds on its market leading valve performance and durability with enhanced coronary access
Funding to support organisations with a mission to improve health outcomes
The VT research will provide important clinical evidence in an underserved patient population
Survey of 1,000 U.S. surgeons finds digital tech like AI and live streaming crucial to closing surgical care gaps in under-resourced regions.
Global expansion of the Avalus Ultra valve continues in Western Europe while company highlights robust, innovative Cardiac Surgery portfolio at EACTS in Lisbon
Bolsters Medtronic Cardiac Surgery’s comprehensive portfolio of cardiac surgical and respiratory innovation
Company recognized among top 52 global companies making positive social impact through core business strategy
ADAPT-PD trial methods and preliminary data published in npj Parkinson’s disease
Dr. James Porter will represent the company this week — including from the Hugo™ console to perform a live partial nephrectomy — at Europe’s biggest urology conference
Annual award celebrates companies fostering cultures of innovation
State-of-the-art facility based in Singapore aims to accelerate adoption of Robotics and AI across Southeast Asia through training and education, improving access to new healthcare technologies and delivering better care experiences across the region
The company will present clinical evidence in young children, pregnancy and type 2 diabetes*
Post-market data collection will add real-world experience to established safety, efficacy, and efficiency evidence profile
New MRI labeling extends active scan time for Medtronic DBS systems
First ever FDA approval provides more options to meet patients’ personalized needs, including those with Parkinson’s disease
Deal expands Pain Interventions portfolio, now offering both unipedicular and bipedicular vertebral augmentation solutions
New York Valves 2024: Late-breaking data included a SMART Trial secondary analysis showing significantly less bioprosthetic valve dysfunction with Evolut TAV across the entire range of small annulus areas when compared with the Edwards Sapien 3™ TAV platform, and CoreValve-Evolut pooled analysis demonstrating valve performance and durability benefits versus surgery.
Dr. Petrovski’s expertise will further strengthen Medtronic clinical and scientific activities to help people with diabetes live better with technology
Medtronic will present the latest data on its MiniMed™ 780G insulin pump and showcase the company’s latest CareLink™ experience launching globally this month
Medtronic, a global leader in medical technology, announced today that it has received U.S. FDA Breakthrough Device designation for Infuse™ bone graft with an intervertebral fusion device and a...
Offering comprehensive support for precise sub-lobar resection surgeries for patients with early-stage lung cancer, and providing treatment that leads to improvements in patients’ prognosis
The company is pursuing hernia and gynecology indications along with urology as it progresses plans to bring choice in robotic surgery technology and partnership to the U.S. Medtronic, a global...
Preliminary findings of the first and only head-to-head trial comparing standard-of-care CT-guided biopsy with electromagnetic navigation bronchoscopy (ENB) for the diagnosis of lung nodules demonstrate non-inferiority and fewer complications when using ENB
Medtronic has modernized its Reveal LINQ™ Insertable Cardiac Monitor (ICM) with artificial intelligence capabilities to reduce false alerts
Symplicity Spyral is the first renal denervation technology to be approved by the National Medical Products Administration; new, innovative, minimally invasive procedure uses radiofrequency energy to help reduce high blood pressure
Medtronic, the global leader in healthcare technology, today announced the release of important clinical outcomes in two leading transcatheter valve therapies. The results for these studies were...
Study shows the investigational use of the MiniMed™ 780G system improved glycemic control during pregnancy. Medtronic, a global leader in healthcare technology, today announced the results of...
Honorary day celebrates Medtronic roots, 75th anniversary year
Groundbreaking studies in Europe and Singapore demonstrate the Medtronic MiniMed™ 780G system can generate cost-savings for health systems. Medtronic, a global leader in healthcare technology,...
Next-generation Avalus Ultra valve is Medtronic’s most advanced surgical aortic tissue valve built on 10 years of clinical experience with the Avalus™ valve
Patient advocate and youth entrepreneur Grace Bowyer will join company executives, shining light on the critical importance for colon cancer screening
Medtronic today announced it received a license from Health Canada for its Symplicity Spyral™ multi-electrode Renal Denervation (RDN) System. This is indicated for the management of essential...
CRT 2024: Evolut TAVR is a safe, effective, and economically cost-effective treatment option for low-risk severe aortic stenosis patients compared to surgery up to four years
Katie will join colorectal cancer screening advocates and Medtronic leaders in a panel conversation, highlighting new data that reveals a stark gap in colorectal cancer awareness, as well as how AI is making the deadly disease more detectable, preventable
Medtronic, a global leader in medical technology, announced today the launch of the new UNiD™ ePRO service in the United States. This solution will change the way patient outcomes are collected...
Annual list highlights organizations leading the way in business integrity